Lawanda Pekar

With Chemo, Blinatumomab Boosts DFS in Pediatric B-ALL

December 8, 2024

SAN DIEGO — The addition of the bispecific T-cell engager blinatumomab (Blincyto) to chemotherapy greatly boosted 3-year disease-free survival (DFS)...

Lawanda Pekar

With Chemo, Blinatumomab Boosts DFS in Pediatric B-ALL

Saatva New Year Sale 2025: Score $300 Off Editor-Approved Mattresses

How midlife became a crisis

China reports 5 cases of new mpox strain

Want to quit vaping this year? Here’s what the evidence shows so far about effective strategies

Expanded research on COPD and metabolic syndrome would advance patient-centered care, expert argues

One of the Best Deodorants We’ve Tried Was Field-Tested by Active Service Members

Should I Get a Handheld Ultrasound?

Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

Brick by colorful brick: LEGO helps bridge gap between midwifery and medical students

Canada reports first case of bird flu in a person

Saatva New Year Sale 2025: Score $300 Off Editor-Approved Mattresses

How midlife became a crisis

China reports 5 cases of new mpox strain

Want to quit vaping this year? Here’s what the evidence shows so far about effective strategies

Expanded research on COPD and metabolic syndrome would advance patient-centered care, expert argues

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories